1. Pharmacogenetics of Risperidone‐Induced Insulin Resistance in Children and Adolescents with Autism Spectrum Disorder
   Chonlaphat Sukasem et al, 2018, Basic & Clinical Pharmacology & Toxicology CrossRef
2. Prognostic significance of SOCS3 and its biological function in colorectal cancer
   Qinjun Chu et al, 2017, Gene CrossRef
3. Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
   Ting Li et al, 2019, Lipids in Health and Disease CrossRef
4. Understanding the Effects of Antipsychotics on Appetite Control
   Sayani Mukherjee et al, 2022, Frontiers in Nutrition CrossRef
5. A novel chi‐square statistic for detecting group differences between pathways in systems epidemiology
   Zhongshang Yuan et al, 2016, Statistics in Medicine CrossRef
6. SOCS6 is a selective suppressor of receptor tyrosine kinase signaling
   Nuzhat N. Kabir et al, 2014, Tumor Biology CrossRef
7. Dysfunctional microRNA-144-3p/ZBTB20/ERK/CREB1 signalling pathway is associated with MK-801-induced schizophrenia-like abnormalities
   Bo Pan et al, 2023, Brain Research CrossRef
8. SOCS3 and its role in associated diseases
   Yanlin Yin et al, 2015, Human Immunology CrossRef
9. Risperidone effects on heterochromatin: the role of kinase signaling
   B Feiner et al, 2019, Clinical and Experimental Immunology CrossRef
10. Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice
    Hsiao-Pei Tsai et al, 2021, International Journal of Molecular Sciences CrossRef
11. Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications
    Mohitosh Biswas et al, 2024, Frontiers in Pharmacology CrossRef
12. Research Advances on Suppressor of Cytokine Signaling 3 (SOCS3) in Animal Carbohydrate and Lipid Metabolism Processes
    Wuyi Liu et al, 2022, Pakistan Journal of Biological Sciences CrossRef
13. The role of wogonin in controlling SOCS3 expression in neuronal cells
    Kung-Woo Nam et al, 2014, Biochemical and Biophysical Research Communications CrossRef
14. Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
    Francky Teddy Endomba et al, 2020, Lipids in Health and Disease CrossRef
15. Hyperleptinemia contributes to antipsychotic drug–associated obesity and metabolic disorders
    Shangang Zhao et al, 2023, Science Translational Medicine CrossRef
16. Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders
    Pornpen Srisawasdi et al, 2017, Clinical Biochemistry CrossRef
17. Deciphering Risperidone-Induced Lipogenesis by Network Pharmacology and Molecular Validation
    Yun Fu et al, 2022, Frontiers in Psychiatry CrossRef
18. Molecular pathway analysis associates alterations in obesity-related genes and antipsychotic-induced weight gain
    Henrik Thyge Corfitsen et al, 2020, Acta Neuropsychiatrica CrossRef
19. Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin
    Juan Antonio Flores-Cordero et al, 2022, International Journal of Molecular Sciences CrossRef
20. Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice
    Geng-Ruei Chang et al, 2021, Pharmaceuticals CrossRef